Channelle Pharma Collaborated with SAP to Advance Pharma Manufacturing Excellence
Published: 14 May 2026
Author: Shivani Zoting
A global pharmaceutical leader in human and animal health, Channelle Pharma, announced a strategic partnership with SAP to apply SAP S/4HANA cloud and SAP business AI. It highlights a massive investment in developing a modern, scalable digital foundation developed for faster time-to-market for innovative medications and enhances operational visibility. It further helps to improve data governance.
It is currently exporting to over 90 countries with expansive operations across Ireland, Portugal, and Jordan. Channel Pharma is working deliberately for continued international growth. The company is modernizing its end-to-end operational value chain, aiming to support such an ambitious move.
According to Precedence Research, the AI in pharma supply chain market size was estimated at USD 2.85 billion in 2025 and is predicted to increase from USD 3.54 billion in 2026 to approximately USD 24.69 billion by 2035, expanding at a CAR of 24.10% from 2026 to 2035 due to the demand for increased resilience, reduced waste, and improved regulatory compliance and real-time monitoring to prevent possible spoilage.
By developing a robust digital core, Channel Pharma will fulfill higher expectations for GDP regulatory compliance. It further helps modernize core finance and supply chain processes. This transformation will be delivered as a single-phase program with a targeted go-live of late 2026.
CEO of Chanelle Pharma, Aiding Dempsey, said, “This strategic partnership with SAP marks a pivotal moment in our growth trajectory. We are investing heavily in a scalable digital foundation that will accelerate our time-to-market and drive global manufacturing excellence. SAP S/4HANA Cloud and Business AI give us the competitive advantage to pioneer the future of the pharmaceutical industry while maintaining the highest standards of GMP compliance.”
A recent report by Precedence Research highlights that the AI in the pharm supply chain market is benefiting from increasing demand for forecasting results in the pharma supply chain, the need for inventory optimization, and strict regulatory proposals.